Resuming VYKAT™ XR Treatment Shows Significant Benefits for Prader-Willi Syndrome Patients, New Data Reveals

Soleno Therapeutics recently announced new findings regarding its investigational drug VYKAT™ XR (diazoxide choline extended-release tablets) for the treatment of Prader-Willi syndrome (PWS), as detailed at GlobeNewswire. The data, which…

Continue Reading Resuming VYKAT™ XR Treatment Shows Significant Benefits for Prader-Willi Syndrome Patients, New Data Reveals